Focused Technology Research and Development (R01 Clinical Trial Not Allowed)
About
This Notice of Funding Opportunity (NOFO) supports projects relevant to the NIGMS mission that focus solely on the development of technologies with potential to enable acquisition of biomedical knowledge. Projects should be justified in terms of technical innovation and utility of such technical innovation for impacting future biomedical research. Outcomes or products of the proposed project should significantly advance the current state of the art and be sufficiently characterized for application in addressing a broad range of biomedical research questions.
The Focused Technology Research and Development (R01 Clinical Trial Not Allowed) grant supports innovative biomedical technology development projects aligned with the National Institute of General Medical Sciences (NIGMS) mission. This funding opportunity is designed for researchers and institutions seeking to advance the state-of-the-art in biomedical research tools and technologies. The grant prioritizes projects that develop novel technologies with broad applicability across multiple biomedical research domains, rather than single-use solutions. Eligible applicants include HBCUs, Hispanic-serving institutions, Alaska Native and Native Hawaiian serving institutions, AANAPISIs, Indian/Native American tribal governments, faith-based and community-based organizations, and eligible federal agencies. Researchers should apply if their projects focus on technical innovation with clear utility for the biomedical research community. The grant explicitly excludes clinical trial components, making it ideal for pure technology development, methodology advancement, and tool creation. Successful projects must demonstrate significant innovation, technical rigor, and potential to impact future biomedical research across diverse applications. This is a competitive federal funding opportunity for institutions committed to advancing research infrastructure and capabilities.
Funding Facts
● Applications openDeadline
January 7, 2028
Who can apply
Last verified July 5, 2026 · Source: Grants.gov
Grant Details
Funding Range
Varies by cycle
Deadline
2028-01-07
Grant Type
federal
Application Cycle
Annual with specific deadline cycles
Best For
Research institutions, HBCUs, minority-serving institutions, and community-based organizations developing biomedical research technologies
Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Govern
Frequently Asked Questions
Who is eligible for Focused Technology Research and Development (R01 Clinical Trial Not Allowed)?
Eligible applicants include HBCUs, Hispanic-serving institutions, Alaska Native and Native Hawaiian serving institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Indian/Native American tribal governments, faith-based and community-based organizations, and eligible federal agencies. For a complete list of eligible organization types and specific eligibility requirements, visit the official NIGMS funding opportunity announcement.
How much funding does Focused Technology Research and Development (R01 Clinical Trial Not Allowed) provide?
Specific funding amounts vary by cycle and are not specified in this listing. Please visit the official NIGMS Notice of Funding Opportunity (NOFO) page for current award ranges and budget guidelines for this funding cycle.
How do I apply for Focused Technology Research and Development (R01 Clinical Trial Not Allowed)?
Applications are typically submitted through Grants.gov or the NIH ASSIST portal. Review the official NIGMS NOFO for specific submission requirements, application components, formatting guidelines, and the complete application process. Ensure your institution has established NIH grant submission procedures and obtain any required institutional approvals before submitting.
What can Focused Technology Research and Development (R01 Clinical Trial Not Allowed) funding be used for?
Funding supports development of biomedical technologies with broad research applications. Projects should focus on technical innovation, methodology advancement, and creating tools that significantly advance the current state-of-the-art. Funding is specifically restricted to technology development—clinical trials are not permitted. The technology must be sufficiently characterized for application across a broad range of biomedical research questions.
Last updated: July 5, 2026